πŸ‡ΊπŸ‡Έ PROUDLY AMERICAN COMPANY β€” U.S. owned & operated Β· Ships from the USA πŸ‡ΊπŸ‡Έ
For research purposes only Β· Not for human consumption Β· You must be 21+ to purchase
Home / News / GHK-Cu and the Hair Follicle
Mechanism Deep-Dive Published August 2, 2026

GHK-Cu and the Hair Follicle: What the Research Actually Reports

GHK-Cu β€” the copper-binding tripeptide glycyl-L-histidyl-L-lysine β€” is the fastest-growing peptide search term of 2026, driven largely by viral interest in copper peptides for hair. Search interest and evidence strength are different things, and in this case they have diverged sharply. This explainer separates the two: what the follicle literature reports, where the evidence is strongest, and where it thins out.

What GHK-Cu is

GHK is a naturally occurring tripeptide first isolated from human plasma, with a high affinity for copper(II) ions; the complexed form is written GHK-Cu. Plasma levels of GHK are reported to decline with age, which is the origin of much of the interest in it. Structurally it is tiny β€” three amino acids β€” which is part of why it has been studied so widely in topical and matrix formulations.

The reported follicle mechanisms

Research literature describes several routes by which GHK-Cu is proposed to interact with follicle biology. These are mechanisms under investigation, not established outcomes:

The minoxidil comparison

The single most-cited hair-specific finding is a 2023 study reporting that GHK-Cu initiated follicle growth at day 6 versus day 9 for 5% minoxidil. It is worth reading that result carefully. Time-to-initiation is not the same as total regrowth, density, or durability of effect β€” it measures how quickly something starts, not how much it ultimately achieves. A three-day difference in onset in a controlled model is an interesting mechanistic signal and a weak basis for any broader conclusion.

Where the evidence is genuinely stronger: wound healing

The hair application is the popular one; the wound-healing application is the better-evidenced one. GHK-Cu is reported to promote keratinocyte migration and support blood vessel formation at injury sites, with multiple animal and cell-culture studies documenting faster wound closure. A 2020 randomized controlled trial in diabetic ulcers reported that a GHK-Cu matrix dressing reduced healing time by roughly 28% versus standard care β€” a human RCT, which is a materially higher evidence tier than anything in the hair literature.

This asymmetry is the most useful thing to know about GHK-Cu: the mechanism people search for is not the mechanism the evidence best supports.

The honest limits

At a glance
  • Compound: glycyl-L-histidyl-L-lysine complexed with copper(II)
  • Reported follicle mechanisms: dermal papilla signaling, anagen prolongation, perifollicular microcirculation, matrix remodeling
  • Most-cited hair finding: 2023 study, follicle growth initiation day 6 vs day 9 for 5% minoxidil
  • Strongest evidence tier: wound healing β€” 2020 RCT, diabetic ulcers, ~28% reduction in healing time with a GHK-Cu matrix dressing
  • Regulatory status: no FDA approvals for any medical indication as of 2026
  • Search context: fastest-growing peptide search term of 2026 (+1,016% year over year)
Research use only. This article summarizes published preclinical and clinical research. It is not medical advice and makes no safety, efficacy, or treatment claim for humans or animals. All products sold by Universe Peptide are supplied strictly for laboratory research only, not for human or animal consumption, 21+. No dosing or administration guidance is provided.

GHK-Cu for laboratory research

Universe Peptide supplies GHK-Cu for in-vitro laboratory research, with a third-party Certificate of Analysis (COA) available for each lot:

Browse research peptides β†’

Related reading

Sources & further reading